La enfermedad de hígado graso no alcohólico (EHGNA) es una de las principales causas de morbilidad hepática global, asociada con factores como obesidad, resistencia a la insulina y síndrome metabólico. La prevalencia global de la enfermedad se estima en un 25% en adultos. Su progresión puede llevar a complicaciones graves como la cirrosis y el carcinoma hepatocelular. Recientemente, se ha enfocado la investigación en el eje intestino-hígado como un mecanismo clave en la fisiopatología de la EHGNA, y se han explorado tratamientos que modulen la microbiota intestinal, como el kéfir, una bebida láctea fermentada. El kéfir ha mostrado en estudios experimentales efectos antioxidantes, antiinflamatorios y beneficios sobre el metabolismo lipídico. En modelos animales, se ha demostrado que los péptidos derivados del kéfir reducen indicadores como los niveles de ALT, triglicéridos e insulina. Sin embargo, la evidencia clínica en humanos es limitada. Un ensayo reciente de 8 semanas con 80 pacientes con NAFLD encontró mejoras significativas en el colesterol HDL y la masa libre de grasa, pero no en las aminotransferasas hepáticas o en otros indicadores metabólicos. En esta revisión sistemática, se examinaron estudios clínicos que analizaron el efecto del kéfir en la progresión de la EHGNA. Los resultados indicaron efectos limitados, pero positivos, sobre ciertos marcadores metabólicos como el colesterol HDL y la masa libre de grasa. Sin embargo, no se observaron mejoras significativas en la función hepática o en los marcadores inflamatorios. La falta de evidencia sólida sugiere que se necesitan más estudios controlados para evaluar el potencial terapéutico del kéfir en la EHGNA. Se recomienda la realización de investigaciones futuras con diseños más robustos y un enfoque más específico en los efectos del kéfir sobre la microbiota intestinal y los mecanismos moleculares involucrados.
The “golden hour” is an international protocol, spearheaded by St. Jude Children’s Research Hospital, for the management of pediatric cancer patients (ALL). Objective: To evaluate the impact of an educational intervention on nursing staff regarding the implementation of the “golden hour” protocol for patients with acute lymphoblastic leukemia (ALL). Methodology: A quasi-experimental study was conducted based on a quality improvement model that employs a collaborative approach and continuous improvement methodology. The study was carried out in emergency departments at various hospitals among 110 nurses working different shifts and was conducted in three phases:Phase I: adaptation and validation of the measurement instrument to assess participants’ knowledge level before the educational intervention; Phase II: design and implementation of a training program through theoretical and practical sessions on the “Golden Hour” protocol; and Phase III: assessment of participants’ knowledge before and after training and evaluation of the educational program’s impact. Descriptive and comparative statistical analysis was performed using SPSS version 30.0. Results: Before the educational intervention, 71% of participants were at the low level, 25% at the medium level, and 4% at the high level. Following the educational intervention, the high level reached 89%, the medium level decreased to 5%, and the low level to 1%. Conclusions: Following the implementation of the educational intervention, a significant improvement was observed in knowledge, attitude, and practice regarding the “golden hour” protocol in the care of pediatric patients with Acute Lymphoblastic Leukemia (ALL). There was a significant increase in understanding of key timeframes, warning signs, and essential therapeutic measures during the first hour of care, as well as a greater ability to prioritize key interventions, such as the timely administration of antibiotics, monitoring of vital signs, and identification of early complications, such as septic shock.
Bioethics plays a fundamental role in the development and regulation of organ transplantation, addressing ethical dilemmas related to the procurement, allocation, and access to available organs. This article analyzes the main bioethical principles involved in organ transplantation, such as autonomy, justice, beneficence, and nonmaleficence, as well as the ethical challenges that arise in living and postmortem donation. It also examines controversial issues, such as the illegal organ trade, informed consent, and equity in global organ distribution. It concludes that bioethics is essential to ensuring fair and transparent transplant practices, promoting a balance between medical advancement and respect for human rights.